FDA Adverse Event Malfunction Summary report: N

VALIANT CAPTIVIA

MDR report key: 3265115 · Received August 5, 2013

Report

Report Number
2953200-2013-01502
Event Type
Malfunction
Date Received
August 5, 2013
Date of Event
July 8, 2013
Report Date
July 8, 2013
Manufacturer
MEDTRONIC IRELAND
Product Code
MIH
PMA / PMN Number
P100040
Product Problem
Yes
Report Source
Manufacturer report
Reporter Location
JA
Reporter Occupation
PHYSICIAN

Narratives

Additional Manufacturer Narrative · 1

(B)(4). EVALUATION, RESULTS: (CAUSE OF EVENT IS UNKNOWN); FAILURE TO FOLLOW INSTRUCTIONS (USER INSPECTED DEVICE AND CONTINUED TO USE THE ALLEGEDLY DEFECT DEVICE); UNAPPROVED USE OF DEVICE (PRE-OPERATIVE RUPTURE). CONCLUSIONS: (CAUSE OF EVENT IS UNKNOWN); OFF ¿LABEL, UNAPPROVED OR CONTRAINDICATED USE (PRE-OPERATIVE RUPTURE); FAILURE TO FOLLOW INSTRUCTIONS (USER INSPECTED DEVICE AND CONTINUED TO USE THE ALLEGEDLY DEFECT DEVICE).

Description of Event or Problem · 1

A VALIANT CAPTIVIA STENT GRAFT SYSTEM WAS IMPLANTED IN A PATIENT FOR THE ENDOVASCULAR TREATMENT OF A FUSIFORM AND SACCULAR THORACIC AORTIC ANEURYSM IN ZONE 0 AND ZONE 3. PRIOR TO THE INDEX PROCEDURE, THE PATIENT HAD AN OPEN STENT FOR AORTIC ARCH REPLACEMENT OF Y SHAPED DEVICE FOR TAA WITH SMA COILING. BYPASS WAS DONE FROM Y SHAPED CIA TO RIGHT/LEFT RENAL ARTERIES. BYPASS WAS DONE FROM RIGHT CIA TO SMA. CELIAC ARTERY WAS EMBOLIZED WITH TEVAR. THERE WAS NO ENDOLEAK AND THE PROCEDURE WAS COMPLETED. IT WAS REPORTED THAT THE PATIENT WAS BROUGHT IN EMERGENTLY FOUR DAYS LATER WITH A RUPTURED ANEURYSM. WHEN THE 3232200 WAS OPENED, THE BOX STATED IT WAS A 192MM; HOWEVER, IT WAS MEASURED AND FOUND TO BE 178MM WITH RULER FROM ABOVE STERILIZED PACK. THE PHYSICIAN SUCCESSFULLY IMPLANTED THE DEVICE. THE CAUSE OF RUPTURE IS UNKNOWN. NO ADDITIONAL CLINICAL SEQUELAE WERE REPORTED AND THE PATIENT IS FINE.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
365668 VALIANT CAPTIVIA SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT MIH MEDTRONIC IRELAND V01100538

Patients

Seq Age Sex Outcome Treatment
1 00067 YR